Covered recipient · General Payments record
HASAN MOUSLI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$8,409.13
- Reported across 421 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $665.21 | 32 |
| Travel and Lodging | $343.28 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Stryker Corporation | $391.54 | 2 |
| ABBVIE INC. | $356.96 | 19 |
| PFIZER INC. | $115.57 | 5 |
| Neurelis, Inc. | $47.00 | 2 |
| Lilly USA, LLC | $22.89 | 1 |
| EISAI INC. | $19.69 | 1 |
| SCILEX PHARMACEUTICALS INC. | $19.27 | 1 |
| Amneal Pharmaceuticals LLC | $19.06 | 1 |
| Vanda Pharmaceuticals Inc. | $16.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.94 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074725 | CMS |
| ABBVIE INC. | $20.26 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074727 | CMS |
| ABBVIE INC. | $15.62 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074729 | CMS |
| ABBVIE INC. | $23.83 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074731 | CMS |
| ABBVIE INC. | $12.63 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074733 | CMS |
| ABBVIE INC. | $12.74 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074735 | CMS |
| ABBVIE INC. | $18.31 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074737 | CMS |
| ABBVIE INC. | $26.58 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074739 | CMS |
| ABBVIE INC. | $15.14 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074741 | CMS |
| ABBVIE INC. | $12.56 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074743 | CMS |
| ABBVIE INC. | $20.37 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074745 | CMS |
| ABBVIE INC. | $16.31 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074747 | CMS |
| ABBVIE INC. | $26.63 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074749 | CMS |
| ABBVIE INC. | $22.91 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074751 | CMS |
| ABBVIE INC. | $17.20 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074753 | CMS |
| ABBVIE INC. | $19.63 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074755 | CMS |
| ABBVIE INC. | $20.41 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074757 | CMS |
| ABBVIE INC. | $21.77 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074759 | CMS |
| ABBVIE INC. | $17.12 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074761 | CMS |
| Amneal Pharmaceuticals LLC | $19.06 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139195972 | CMS |
| Eisai Inc. | $19.69 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110748310 | CMS |
| Lilly USA, LLC | $22.89 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134980068 | CMS |
| Neurelis, Inc. | $23.25 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648884 | CMS |
| Neurelis, Inc. | $23.75 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648886 | CMS |
| PFIZER INC. | $24.60 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131491807 | CMS |
| PFIZER INC. | $26.00 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131656871 | CMS |
| PFIZER INC. | $20.03 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131763986 | CMS |
| PFIZER INC. | $23.99 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131975185 | CMS |
| PFIZER INC. | $20.95 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132118046 | CMS |
| SCILEX PHARMACEUTICALS INC. | $19.27 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136261128 | CMS |
| Stryker Corporation | $48.26 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119923815 | CMS |
| Stryker Corporation | $343.28 | 02/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119923817 | CMS |
| Vanda Pharmaceuticals Inc. | $16.51 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133913682 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.